IFITM1 plays an important role in the progression of cancer, including that it promotes tumor cell proliferation, invasion, metastasis, angiogenesis, and therapeutic resistance, including endocrine therapy, chemotherapy, and radiotherapy resistance, and it was always served as poor prognostic biomarkers for many cancers (48). This evidence concerns the gene IFITM1 and cancer.